In 1987, famous physicist and Harvard professor Bertrand Halperin predicted the existence of the three-dimensional quantum Hall effect. After 32 years, Associate Professor Zhang Liyuan from the Department of Physics at Southern University of Science and Technology (SUSTech) collaborated with Professor Qiao Zhenhua of the University of Science and Technology of China (USTC), Professor Yang Shengyuan of Singapore University of Technology and Design (SUTD), Professor Yang Kun of Florida State University (FSU), Professor Patrick A. Lee of Massachusetts Institute of Technology (MIT) and Professor Genda Gu of the Brookhaven National Laboratory, in confirming the prediction of the 3D quantum Hall effect. The research results were recently published in well-known international academic journal Nature.

Recently, Associate Professor Zhang Liyuan from the Department of Physics at Southern University of Science and Technology worked with Professor Qiao Zhenhua of the University of Science and Technology of China (USTC), and Associate Professor Shengyuan Yang of Singapore University of Technology and Design (SUTD).

“Three-dimensional quantum Hall effect and metal-insulator transition in ZrTe5”,published on Nature on May, 2019, validates the prediction on Quantum Hall effect in 3D election gas proposed by Bertrand Halperin, a Harvard theoretical physicist in 1987. The research was led by prof. Liyuan ZHANG, department of physics.

The Majorana zero mode in the semiconductor-superconductor nanowire is one of the promising candidates for topological quantum computing.

Pancreatic cancer is thought to be the “king of cancers,” in that it has no obvious symptoms in its earliest stages, and is often only diagnosed after the tumor has metastasized and spread throughout the entire body.

Associate Professor Tian Ruijun’s research group from the Department of Chemistry at Southern University of Science and Technology (SUSTech) joined a global effort over a long period of time to find new ways to target pancreatic cancer cells. Working with the Salk Institute for Biological Sciences, the collective group found that an interaction between pancreatic stellate cells (PSC) and pancreatic cancer cells (PCCs) could be taken advantage of through a key protein. This research was published today in Nature, under the title, “Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring.”